EvansJ, RooneyC, AshwoodF, DattaniN, WormwaldR.Blindness and partial sight in England and Wales. Health Trends1996; 38: 5–12
2.
Chief Medical Officer.The Annual Report of the Chief Medical Officer of the Department of Health for the year 1997.London: Stationery Office, 1998
3.
BingleyPJ, GaleEA.Rising incidence of IDDM in Europe. Diabet Care1989; 12: 289–95
4.
AmosAF, McCartyDJ, ZimmetP.The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med1997; 14 suppl S57
5.
McleodBK, ThompsonJR, RosenthalAR.The presence of retinopathy in the insulin requiring diabetic patients of an English country town. Eye1988; 2: 424–30
6.
MasonJ, DrummondM.Screening for Diabetic Retinopathy by Optometrists: effectiveness and cost effectiveness.York: NHS Centre for Reviews & Dissemination, 2000.
7.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet1998; 352: 837–53
8.
National Screening Committee.First Report of the National Screening Committee.London: Health Departments of the United Kingdom1998
9.
Diabetic Retinopathy Research Group.Indications for photocoagulation treatment of diabetic retinopathy: diabetic retinopathy study report No. 14. Int Ophthalmol Clin1987; 27: 239–53
10.
ETDRS Research Group.Early photocoagulation for diabetic retinopathy: ETDRS Report No. 9. Ophthalmology1991; 98: 766–85
11.
FerrisL.How effective are treatments for diabetic retinopathy?JAMA1993; 269: 1290–1
12.
KleinR, KleinBEK, MossSE, CruickshanksKJ.Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol1999; 117: 1487–94
13.
FouldsWS, MacCuishAC, BarrieT.Diabetic retinopathy in the West of Scotland: its detection, prevalence, and the cost effectiveness of a proposed screening programme. Health Bull (Edinb)1983; 41: 318–26
14.
JamesM, TurnerD, BroadbentDM, VoraJ, HardingS.Cost effective analysis of screening for sight threatening diabetic eye disease. BMJ2000; 320: 1627–31
15.
British Diabetic Association.Optometry Screening for Diabetic Eye Disease.London: British Diabetic Association, 1997
16.
ClarkJB, GreyRHB, LimKKT, Burns-CoxCJ.Loss of vision before ophthalmic referral in blind and partially sighted diabetics in Bristol. Br J Ophthalmol1994; 78: 741–4
17.
GrimshawGM, BakerR, WilsonAD, ThompsonJR, AtkinsonM.Report of the Inter-College Audit of Diabetic Retinopathy Screening.Leicester Clinical Governance Research and Development Unit. Leicester University, 1999
18.
Burns-CoxCJ.Prevention of blindness: a lost opportunity. J Med Screening1996; 3: 169
19.
The St Vincent Task Force For Diabetes.The Report.London: Department of Health and British Diabetic Association, 2000
20.
KleinR, KleinBEK, MossSE, CruickshankKJ.The Wisconsin Epidemiologic Study of Diabetic Retinopathy. The 14 year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Arch Ophthalmol2000; 105: 1801–15
21.
HerbertA, JohnsonJ, PatrickJ.Report of a working party on internal quality assurance for cervical cytology laboratories. Cytopathology1996; 7: 269–70
22.
StrachanF, O'DonnellM, GrantA.The Role of Digital Imaging in Diabetic Retinopathy.Aberdeen: University of Aberdeen, 1999
23.
GibbonsRL, OwensDR, AllenJC.Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides. Diabetologia1998; 14: 59–64
24.
British Diabetic Association.Retinal Photographic Screening for Diabetic Eye Disease.London: British Diabetic Association, 1997
25.
BurnettS, HurwitzB, DaveyCThe implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study. Diabet Med1998; 15 (suppl. 3): S38–43